The modulation of radiation-induced cell death by genistein in K562 cells: Activation of thymidine kinase 1

Cell Research

Volumn 14, Issue 4, 2004, Pages 295-302

  Jeong, Min Ho ^a   Jin, Young Hee ^a   Kang, Eun Young ^a   Jo, Wol Soon ^a   Park, Hwan Tae ^a   Lee, Jae Dong ^b   Yoo, Yeo Jin ^a   Jeong, Soo Jin ^a,c  

^a Dong A University College of Medicine   (South Korea)

^b Pusan National University   (South Korea)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Cell cycle; Cell death; Genistein; K562; Radiation; Thymidine kinase 1

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLIN A; CYCLIN B; CYCLIN B1; GENISTEIN; MESSENGER RNA; THYMIDINE KINASE; THYMIDINE KINASE 1;

ARTICLE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE S PHASE; CELL DEATH; CELL STRAIN K 562; CHRONIC MYELOID LEUKEMIA; DRUG EFFECT; ENZYME ACTIVATION; ENZYMOLOGY; GENE; GENETICS; HUMAN; METABOLISM; METHODOLOGY; NUCLEIC ACID HYBRIDIZATION; PHYSIOLOGY; RADIATION EXPOSURE; TIME;

ANTINEOPLASTIC AGENTS; CELL DEATH; CYCLIN A; CYCLIN B; ENZYME ACTIVATION; G1 PHASE; G2 PHASE; GENES, CDC; GENISTEIN; HUMANS; K562 CELLS; LEUKEMIA, MYELOID, CHRONIC; NUCLEIC ACID HYBRIDIZATION; RNA, MESSENGER; S PHASE; THYMIDINE KINASE; TIME FACTORS;

EID: 16644391772     PISSN: 10010602     EISSN: 17487838     Source Type: Journal    
DOI: 10.1038/sj.cr.7290230     Document Type: Article

References (33)

1. Perona R, Sanchez-Perez I. Control of oncogenesis and cancer therapy resistance. Br J Cancer 2004; 90:573-7.
2. Lozzio CB, Lozzio BB. Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome. Blood 1975; 45:321-34.
3. Bedi A, Zehnbauer BA, Barber JP, et al. Inhibition of apoptosis by BCR-ABL in chronic myeloid leukemia. Blood 1994; 83:2038-44.
4. Efferth T, Fabry U, Glatte P, et al. Expression of apoptosis-related oncoproteins and modulation of apoptosis by caffeine in human leukemic cells. J Cancer Res Clin Oncol 1995; 121:648-56.
5. Li YX, Weber-Johnson K, Sun LQ, et al. Effect of pentoxifylline on radiation-induced G2-phase delay and radiosensitivity of human colon and cervical cancer cells. Radiat Res 1998; 149:338-42.
6. Jeong SJ, Jin YH, Moon CW, et al. Protein tyrosine kinase inhibitors modulate radiosensitivity and radiation-induced apoptosis in K562 cells. Radiat Res 2001; 156: 751-60.
7. Johnson LF, Rao LG, Muench AJ. Regulation of thymidine kinase enzyme level in serum-stimulated mouse 3T6 fibroblasts. Exp Cell Res 1982; 138:79-85.
8. Hallek M, Wanders L, Strohmeyer S, et al. Thymidine kinase: a tumor marker with prognostic value for non-Hodgkin's lymphoma and a broad range of potential clinical applications. Ann Hematol 1992; 65:1-5.
9. Pardee AB. G1 events and regulation of cell proliferation. Science 1989; 246: 603-8.
10. Hengstschlager M, Knofler M, Mullner EW, et al. Different regulation of thymidine kinase during the cell cycle of normal versus DNA tumor virus-transformed cells. J Biol Chem 1994; 269: 13836-42.
11. Chang ZF, Huang DY, Lai TC. Different regulation of the human thymidine kinase promoter in normal human diploid IMR-90 fibroblasts and HeLa cells. J Biol Chem 1995; 270:27374-9.
12. FitzGerald TJ, Daugherty C, Kase K, et al. Activated human N-ras oncogene enhances x-irradiation repair of mammalian cells in vitro less effectively at low dose rate. Implications for increased therapeutic ratio of low dose rate irradiation. Am J Clin Oncol 1985; 8:517-22.
13. He Q, Skog S, Welander I, et al. X-irradiation effects on thymidine kinase (TK): II. The significance of deoxythymidine triphosphate for inhibition of TK1 activity. Cell Prolif 2002; 35:83-92.
14. He Q, Skog S, Welander I, et al. X-irradiation effects on thymidine kinase (TK): I. TK1 and 2 in normal and malignant cells. Cell Prolif 2002; 35:69-81.
15. Gadbois DM, Crissman HA, Tobey RA, et al. Multiple kinase arrest points in the G1 phase of nontransformed mammalian cells are absent in transformed cells. Proc Natl Acad Sci USA 1992; 89:8626-30.
16. Stuart P, Ito M, Stewart C, et al. Induction of cellular thymidine kinase occurs at the mRNA level. Mol Cell Biol 1985; 5:1490-7.
17. Huang DY, Chang ZF. Interaction of human thymidine kinase 1 with p21(Waf1). Biochem J 2001; 356:829-34.
18. Adler R, McAuslan BR. Expression of thymidine kinase variants is a function of the replicative state of cells. Cell 1974; 2:113-7.
19. Roninson IB, Dokmanovic M. Induction of senescence-associated growth inhibitors in the tumor-suppressive function of retinoids. J Cell Biochem 2003; 88:83-94.
20. Roninson IB. Tumor senescence as a determinant of drug response in vivo. Drug Resist Updat 2002; 5:204-8.
21. Chan TA, Hermeking H, Lengauer C, et al. 14-3-3Sigma is required to prevent mitotic catastrophe after DNA damage. Nature 1999; 401:616-20.
22. Pignolo RJ, Martin BG, Horton JH, et al. The pathway of cell senescence: WI-38 cells arrest in late G1 and are unable to traverse the cell cycle from a true G0 state. Exp Gerontol 1998; 33: 67-80.
23. Matuoka K, Yu CK. Nuclear factor Y (NF-Y) and cellular senescence. Exp Cell Res 1999; 253:365-71.
24. Crompton NE. Telomeres, senescence and cellular radiation response. Cell Mol Life Sci 1997; 53:568-75.
25. Chen KY. Transcription factors and the down-regulation of G1/S boundary genes in human diploid fibroblasts during senescence. Front Biosci 1997; 2:d417-26.
26. Chen Q, Ames BN. Senescence-like growth arrest induced by hydrogen peroxide in human diploid fibroblast F65 cells. Proc Natl Acad Sci USA 1994; 91:4130-4.
27. Chang ZF, Huang DY. Regulation of thymidine kinase expression during cellular senescence. J Biomed Sci 2001; 8:176-83.
28. Marx J. Cell biology. Cell cycle inhibitors may help brake growth as cells develop. Science 1995; 267:963-4.
29. Schwartz B, Avivi-Green C, Polak-Charcon S. Sodium butyrate induces retinoblastoma protein dephosphorylation, p16 expression and growth arrest of colon cancer cells. Mol Cell Biochem 1998; 188:21-30.
30. Nygard M, Wahlstrom GM, Gustafsson MV, et al. Hormone-dependent repression of the E2F-1 gene by thyroid hormone receptors. Mol Endocrinol 2003; 17:79-92.
31. Chen Y, Sokoloski JA, Chu E, et al. Regulation of the expression of enzymes involved in the replication of DNA in chemically induced monocytic/macrophagic differentiation of HL-60 leukemia cells. Leuk Res 1998; 22:697-703.
32. Mullan PB, McKenna PG, McKelvey-Martin VJ. Activities of potential tumour marker enzymes during induced differentiation in HL-60 and U-937 cells. Br J Biomed Sci 1997; 54:91-9.
33. Filanovskaia LI, Togo AV, Shcherbakova EG, et al. Thymidine kinase activity in leukocytes from patients with chronic myeloid leukemia at various periods in the disease. Vopr Med 1994; 40:29-32.